Completed PHASE2 INTERVENTIONAL 2-arm NCT01117753

Research on Outpatient Adolescent Treatment for Comorbid Substance Use and Internalizing Disorders

Stage II Research on Outpatient Treatment for Adolescents With Comorbidity

Sponsor: Medical University of South Carolina

Conditions Anxiety Disorder Depressive Disorder Substance-Related Disorders

Interventions OutPatient Treatment for Adolescents (OPT-A) Treatment As Usual

Updated 5 times since 2017 Last updated: Apr 10, 2015 Started: Jul 31, 2009 Primary completion: Jun 30, 2014 Completion: Jun 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Anxiety Disorder and Depressive Disorder, this trial is completed. The trial is conducted by Medical University of South Carolina and has accumulated 5 data snapshots since 2009. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jul 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of South Carolina
National Institute on Drug Abuse (NIDA)

Data source: Medical University of South Carolina

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Charleston, United States